<DOC>
	<DOCNO>NCT02125305</DOCNO>
	<brief_summary>This study aim investigate pharmacokinetics/pharmacodynamics metformin IR oral administration healthy elderly male volunteer .</brief_summary>
	<brief_title>Clinical Study Investigate Pharmacokinetics Pharmacodynamics Metformin Elderly</brief_title>
	<detailed_description />
	<mesh_term>Metformin</mesh_term>
	<criteria>Males age 6585 year body mass index ( BMI ) 1828 kg/m2 Good health base complete medical history , physical examination , vital sign , electrocardiography ( ECG ) , clinical laboratory evaluation include hematology ( blood cell count , hemoglobin , platelet count ) , liver function test ( aspartate aminotransferase ( AST ) , alanine aminotransferase ( ALT ) , bilirubin ) , serum creatinine , blood glucose urinalysis If clinically relevant disorder Past history diabetes clinical finding suspect diabetes Abnormal clinical laboratory value ( i.e. , platelet ≤ 75,000/mm3 , hemoglobin ≤ 9 g/dL , neutrophil absolute ≤ 1000/mm3 , fast glucose &gt; 126mg/dL , creatinine ≥ 1.5 mg/dL , AST , ALT &gt; 3 × upper limit normal )</criteria>
	<gender>Male</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Metformin</keyword>
	<keyword>Pharmacokinetics/ Pharmacodynamics</keyword>
</DOC>